ICCAS OpenIR
Enhanced Chemotherapy Efficacy by Sequential Delivery of siRNA and Anticancer Drugs Using PEI-Grafted Graphene Oxide
Zhang, Liming1,2,3; Lu, Zhuoxuan1; Zhao, Qinghuan1; Huang, Jie1; Shen, He1; Zhang, Zhijun1
2011-02-18
Source PublicationSMALL
ISSN1613-6810
Volume7Issue:4Pages:460-464
DOI10.1002/smll.201001522
Indexed BySCI
Language英语
WOS IDWOS:000288080400005
PublisherWILEY-BLACKWELL
Citation statistics
Cited Times:362[WOS]   [WOS Record]     [Related Records in WOS]
Document Type期刊论文
Identifierhttp://ir.iccas.ac.cn/handle/121111/72294
Collection中国科学院化学研究所
Corresponding AuthorZhang, Zhijun
Affiliation1.CAS, Suzhou Inst Nanotech & Nanobion, Suzhou 215123, Peoples R China
2.CAS, Grad Univ, Beijing 100039, Peoples R China
3.CAS, Inst Chem, Beijing 100039, Peoples R China
Recommended Citation
GB/T 7714
Zhang, Liming,Lu, Zhuoxuan,Zhao, Qinghuan,et al. Enhanced Chemotherapy Efficacy by Sequential Delivery of siRNA and Anticancer Drugs Using PEI-Grafted Graphene Oxide[J]. SMALL,2011,7(4):460-464.
APA Zhang, Liming,Lu, Zhuoxuan,Zhao, Qinghuan,Huang, Jie,Shen, He,&Zhang, Zhijun.(2011).Enhanced Chemotherapy Efficacy by Sequential Delivery of siRNA and Anticancer Drugs Using PEI-Grafted Graphene Oxide.SMALL,7(4),460-464.
MLA Zhang, Liming,et al."Enhanced Chemotherapy Efficacy by Sequential Delivery of siRNA and Anticancer Drugs Using PEI-Grafted Graphene Oxide".SMALL 7.4(2011):460-464.
Files in This Item:
There are no files associated with this item.
Related Services
Recommend this item
Bookmark
Usage statistics
Export to Endnote
Google Scholar
Similar articles in Google Scholar
[Zhang, Liming]'s Articles
[Lu, Zhuoxuan]'s Articles
[Zhao, Qinghuan]'s Articles
Baidu academic
Similar articles in Baidu academic
[Zhang, Liming]'s Articles
[Lu, Zhuoxuan]'s Articles
[Zhao, Qinghuan]'s Articles
Bing Scholar
Similar articles in Bing Scholar
[Zhang, Liming]'s Articles
[Lu, Zhuoxuan]'s Articles
[Zhao, Qinghuan]'s Articles
Terms of Use
No data!
Social Bookmark/Share
All comments (0)
No comment.
 

Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.